ResearcherSun Yat-sen UniversityActive in the last 2 years
Qian Shen
Matched on ORCID iD 0000-0002-4097-6775; OpenAlex author ID A5101667341. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jconrel.2025.113588↗
- DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway. Co-author DOI 10.1111/jcmm.17612↗
- Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2021.121264↗
- CircRNA circ_0092314 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells via Elevating the Expression of S100P by Sponging miR-671. Co-author DOI 10.3389/fonc.2021.675442↗
- Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway. Co-author DOI 10.3389/fonc.2021.754146↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaoding Xu · 2 shared papers, 2022–2025 · strength 0.41
- Paper Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic … DOI 10.1016/j.jconrel.2025.113588↗
- Paper Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pa… DOI 10.1016/j.biomaterials.2021.121264↗
- Huiting Xu · 2 shared papers, 2021–2023 · strength 0.34
- Paper DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI… DOI 10.1111/jcmm.17612↗
- Paper Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating… DOI 10.3389/fonc.2021.754146↗
- Jinjin Chen · 1 shared paper, 2025 · strength 0.22
- Zixi Zhang · 1 shared paper, 2025 · strength 0.22
- Sixian Zhu · 1 shared paper, 2023 · strength 0.19
- Qiang Fu · 1 shared paper, 2023 · strength 0.19
- Shuwen Cao · 1 shared paper, 2022 · strength 0.19
- Qiang Fu · 1 shared paper, 2021 · strength 0.15
- Qiang Fu · 1 shared paper, 2021 · strength 0.14
- Gang Zheng · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.